CytoSorbents Corporation (CTSO)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current CTSO market cap is 56.32M. The company's latest EPS is USD -0.5213 and P/E is -1.94.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 8.81M | 8.67M | 9.79M | 9.9M | 9.39M |
| Operating Income | -7.42M | -9.34M | -4.93M | -3.42M | -4.4M |
| Net Income | -9.19M | -5.84M | -6.36M | -4.14M | -2.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 24.95M | 41.01M | 43.17M | 34.69M | 36.35M |
| Operating Income | -18.97M | -10.37M | -22.74M | -31.52M | -31.21M |
| Net Income | -19.27M | -7.84M | -24.56M | -32.81M | -28.51M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 47.58M | 53.26M | 47.07M | 53.43M | 47.8M |
| Total Liabilities | 29.06M | 29.99M | 28.14M | 36.69M | 34.81M |
| Total Equity | 18.51M | 23.28M | 18.93M | 16.74M | 13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 27.38M | 89.95M | 89.52M | 63.23M | 53.26M |
| Total Liabilities | 23.97M | 10.74M | 26.94M | 27.86M | 29.99M |
| Total Equity | 3.42M | 79.22M | 62.58M | 35.38M | 23.28M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.25M | -21.66M | -4.83M | -9.63M | -12.09M |
| Investing | -800k | -936k | -127k | -246k | -545k |
| Financing | 2.26M | 14.47M | -572k | 9.26M | 9.16M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -17.93M | -5.61M | -14.01M | -28.23M | -21.66M |
| Investing | -1.52M | -1.68M | -4.28M | -6.46M | -936k |
| Financing | 9.35M | 66.35M | 715k | 4.96M | 14.47M |
| Market Cap | 56.32M |
| Price to Earnings Ratio | -1.94 |
| Price to Sales Ratio | 1.52 |
| Price to Cash Ratio | 3.91 |
| Price to Book Ratio | 2.37 |
| Dividend Yield | - |
| Shares Outstanding | 54.68M |
| Average Volume (1 week) | 207.13k |
| Average Volume (1 Month) | 611.12k |
| 52 Week Change | 0.98% |
| 52 Week High | 1.59 |
| 52 Week Low | 0.70 |
| Spread (Intraday) | 0.04 (3.85%) |
| Company Name | CytoSorbents Corporation |
| Address |
874 walker rd ste c dover, delaware 19904 |
| Website | https://www.cytosorbents.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
